Real-time monitoring of cell detachment remains challenging, however, despite being critical for timely bioreactor transfer ...
Data show verekitug prevents TSLP binding to the TSLP receptor by occupying ligand binding sites –– Additionally, findings show that verekitug ...
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL ...
Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 grant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback